Dynamin-Related Protein Drp1 Regulates Cardiac Excitation-Contraction-Bioenergetics Coupling
动力相关蛋白 Drp1 调节心脏兴奋-收缩-生物能耦合
基本信息
- 批准号:10063889
- 负责人:
- 金额:$ 62.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-01 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdrenergic ReceptorAdultArchitectureBindingBiochemistryBioenergeticsBiological AssayBiological MarkersBrainCardiacCardiac MyocytesCardiomyopathiesCell DeathCell NucleusCell VolumesCell divisionCellsCellular biologyCessation of lifeChronicCouplingCytoskeletonDataDiabetes MellitusDiseaseDynaminEchocardiographyElectron MicroscopyElectronsEndoplasmic ReticulumEnergy MetabolismExhibitsF-ActinFaceFibroblastsFluorescence Resonance Energy TransferFrequenciesFunctional disorderGap JunctionsGenerationsGenesGuanosine TriphosphateHeartHeart HypertrophyHeart failureHot SpotImageIn SituIn VitroInfusion proceduresInjuryIsoproterenolKnock-inKnock-outKnowledgeLeadLeftLinkLocationMalignant NeoplasmsMammalian CellMediatingMembraneMembrane PotentialsMessenger RNAMicrofilamentsMicroscopyMitochondriaMolecularMolecular BiologyMovementMuscle CellsMyocardial dysfunctionMyocardiumMyofibrilsNMR SpectroscopyNeurodegenerative DisordersNorthern BlottingOptic AtrophyOrganellesOxidation-ReductionPhosphorylationPhysiologicalPhysiologyProcessProductionProteinsQuality ControlRNA InterferenceRattusReactive Oxygen SpeciesRegulationReportingResearch PersonnelResolutionRespirationRoleSarcolemmaSarcoplasmic ReticulumSignal PathwaySignal TransductionSiteSkeletal MuscleStressTechniquesTestingTherapeutic AgentsTissuesVentricularWorkWorkloadbasecalmodulin-dependent protein kinase IIcell injurycell typedensityhuman diseaseinsightmitochondrial membranemitochondrial permeability transition poremouse modeloocyte maturationoverexpressionrecruitrespiratorytargeted treatment
项目摘要
Project Summary/Abstract
Mitochondrial dynamics, including fission, fusion, and movement, is a fundamental mechanism in
regulating mitochondrial function. Dynamin-related protein 1 (Drp1) is the major GTP hydrolyzing
protein that is responsible for fission. Studies have shown that Drp1 is abundantly expressed in
adult cardiac myocytes. Paradoxically, compared to numerous cell types, adult cardiac myocytes
exhibit very low frequency in mitochondrial fission. This dichotomy between the abundance of
Drp1 and scarcity of mitochondrial fission has prompted us to investigate the non-canonical roles
of Drp1 in cardiac muscle cells. We hypothesize that Drp1 is strategically accumulated in the
mitochondria associated sarcoplasmic reticulum (SR) membrane (MAM). During excitation-
contraction coupling, the localized high Ca2+ in the SR-mitochondria junctions further increases
the translocation of nearby cytosolic Drp1 to mitochondria. Then, Drp1 is anchored firmly in the
MAM by actin. The activation of Drp1 leads to enhanced mitochondrial respiration for ATP
generation as such the heart can work most effectively and sustainably. However, excessive
Drp1 activation leads to persistent mitochondrial transition pore opening and excessive reactive
oxygen species (ROS) generation that causes cell injury and death. The following three specific
aims are proposed to test this hypothesis. Aim 1: To determine whether and how Drp1 is
preferentially localized in the SR-mitochondria junctions. Aim 2: To determine the molecular
mechanisms by which Drp1 regulates excitation-contraction-bioenergetics coupling. Aim 3: To
determine how chronic over activation of Drp1 leads to dysfunction in the stressed heart. We will
employ multiple techniques, including biochemistry (from in vitro to in situ assays), molecular
biology (gene knock in or knock out, overexpression, RNA interference), cell biology (confocal,
fluorescence resonance energy transfer, super-resolution microscopy, electron microscopy),
cardiac physiology (echocardiogram, NMR spectroscopy), and isoproterenol infusion mouse
model of cardiac hypertrophy and failure, to obtain experimental results that will lead to
mechanistic insights. Successful completion of the proposed aims will allow us to introduce a new
paradigm that describes the regulation of excitation-contraction-bioenergetics-ROS nexus by
Drp1 through localized Ca2+ activation and actin anchoring. This fundamental signaling
mechanism will describe not only how a healthy heart can perform perpetually in face of
enormous workload but also why the over activation of this unique process can lead to heart
failure. Finally, this new knowledge will provide new insights in developing and discovering
therapeutic agents targeting Drp1-mediated signaling pathways for treating heart failure.
项目总结/摘要
线粒体动力学,包括分裂,融合和运动,是一个基本的机制,
调节线粒体功能。动力蛋白相关蛋白1(Dynamin-related protein 1,Drp 1)是GTP的主要水解酶
负责裂变的蛋白质。研究表明,Drp 1在哺乳动物中大量表达,
成体心肌细胞有趣的是,与许多细胞类型相比,成年心肌细胞
线粒体分裂的频率很低这种丰富的
drp 1和线粒体分裂的缺乏促使我们研究非经典的作用,
Drp 1在心肌细胞中的表达。我们假设Drp 1是策略性地积累在
线粒体相关肌浆网(SR)膜(MAM)。在激发过程中-
收缩偶联,SR-线粒体连接中的局部高Ca 2+进一步增加
附近的胞质Drp 1易位到线粒体。然后,Drp 1牢固地锚定在
通过肌动蛋白。Drp 1的激活导致线粒体对ATP的呼吸增强
因此,这一代人的心脏可以最有效和可持续地工作。但过度
drp 1激活导致持续的线粒体过渡孔开放和过度的反应性
氧物质(ROS)的产生导致细胞损伤和死亡。以下三种特定
目的是为了检验这一假设。目的1:确定Drp 1是否以及如何被
优先定位在SR-线粒体连接处。目的2:确定其分子量
Drp 1调节兴奋-收缩-生物能量学耦合的机制。目标3:
确定Drp 1的慢性过度激活如何导致应激心脏功能障碍。我们将
采用多种技术,包括生物化学(从体外到原位测定),分子生物学,
生物学(基因敲入或敲除,过表达,RNA干扰),细胞生物学(共聚焦,
荧光共振能量转移,超分辨率显微镜,电子显微镜),
心脏生理学(超声心动图,NMR光谱学)和异丙肾上腺素输注小鼠
心肌肥大和衰竭模型,以获得将导致
机械的洞察力。成功完成拟议目标将使我们能够推出新的
该范式描述了兴奋-收缩-生物能学-ROS关系的调节,
Drp 1通过局部Ca 2+激活和肌动蛋白锚定。这个基本的信号
这一机制不仅描述了一个健康的心脏如何在面对疾病时永远发挥作用,
巨大的工作量,但也为什么过度激活这个独特的过程会导致心脏
失败最后,这些新知识将为开发和发现
用于治疗心力衰竭的靶向Drp 1介导的信号传导途径的治疗剂。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Unsolved mysteries and controversies of mitochondria in the heart - A virtual special issue in JMCC.
心脏线粒体的未解之谜和争议 - JMCC 的虚拟特刊。
- DOI:10.1016/j.yjmcc.2020.04.022
- 发表时间:2020
- 期刊:
- 影响因子:5
- 作者:Wang,Wang;Sheu,Shey-Shing
- 通讯作者:Sheu,Shey-Shing
Unsolved mysteries and controversies of mitochondria in the heart- A Virtual Special Issue in JMCC: Part III.
心脏线粒体的未解之谜和争议 - JMCC 虚拟特刊:第三部分。
- DOI:10.1016/j.yjmcc.2020.06.009
- 发表时间:2020
- 期刊:
- 影响因子:5
- 作者:Wang,Wang;Sheu,Shey-Shing
- 通讯作者:Sheu,Shey-Shing
Elevated MCU Expression by CaMKIIδB Limits Pathological Cardiac Remodeling.
- DOI:10.1161/circulationaha.121.055841
- 发表时间:2022-04-05
- 期刊:
- 影响因子:37.8
- 作者:Wang P;Xu S;Xu J;Xin Y;Lu Y;Zhang H;Zhou B;Xu H;Sheu SS;Tian R;Wang W
- 通讯作者:Wang W
Unsolved mysteries and controversies of mitochondria in the heart - A virtual special issue in JMCC: Part II.
心脏线粒体的未解之谜和争议 - JMCC 的虚拟特刊:第二部分。
- DOI:10.1016/j.yjmcc.2020.05.015
- 发表时间:2020
- 期刊:
- 影响因子:5
- 作者:Wang,Wang;Sheu,Shey-Shing
- 通讯作者:Sheu,Shey-Shing
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shey-Shing Sheu其他文献
Shey-Shing Sheu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shey-Shing Sheu', 18)}}的其他基金
Crosstalk Ca2+ Signaling between Ryanodine Receptors Type 1 and 2 in the Pathogenesis of Cardiac Hypertrophy and Heart Failure
心脏肥大和心力衰竭发病机制中 1 型和 2 型 Ryanodine 受体之间的串扰 Ca2 信号传导
- 批准号:
10660636 - 财政年份:2023
- 资助金额:
$ 62.87万 - 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
- 批准号:
8011076 - 财政年份:2011
- 资助金额:
$ 62.87万 - 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
- 批准号:
8267661 - 财政年份:2011
- 资助金额:
$ 62.87万 - 项目类别:
ADP: A Master Regulator for Bioenergetics and Ca2+/ROS Signaling in Heart
ADP:心脏生物能学和 Ca2/ROS 信号传导的主调节器
- 批准号:
8311703 - 财政年份:2011
- 资助金额:
$ 62.87万 - 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
- 批准号:
8431698 - 财政年份:2011
- 资助金额:
$ 62.87万 - 项目类别:
ADP: A Master Regulator for Bioenergetics and Ca2+/ROS Signaling in Heart
ADP:心脏生物能学和 Ca2/ROS 信号传导的主调节器
- 批准号:
8198299 - 财政年份:2011
- 资助金额:
$ 62.87万 - 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
- 批准号:
10521270 - 财政年份:2010
- 资助金额:
$ 62.87万 - 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
- 批准号:
10064104 - 财政年份:2010
- 资助金额:
$ 62.87万 - 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
- 批准号:
9887277 - 财政年份:2010
- 资助金额:
$ 62.87万 - 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
- 批准号:
8761519 - 财政年份:2010
- 资助金额:
$ 62.87万 - 项目类别:
相似海外基金
Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
- 批准号:
10603466 - 财政年份:2023
- 资助金额:
$ 62.87万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 62.87万 - 项目类别:
Discovery Grants Program - Individual
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
神经免疫界面的糖皮质激素和肾上腺素能受体信号传导
- 批准号:
RGPIN-2019-04706 - 财政年份:2022
- 资助金额:
$ 62.87万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 62.87万 - 项目类别:
University Undergraduate Student Research Awards
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10629280 - 财政年份:2022
- 资助金额:
$ 62.87万 - 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10448574 - 财政年份:2022
- 资助金额:
$ 62.87万 - 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
- 批准号:
10591688 - 财政年份:2022
- 资助金额:
$ 62.87万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 62.87万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 62.87万 - 项目类别:
University Undergraduate Student Research Awards
The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
淋巴细胞β2肾上腺素受体与趋化因子受体串扰的分子机制
- 批准号:
22K07118 - 财政年份:2022
- 资助金额:
$ 62.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




